| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/17/2003 | WO2002033085A3 Wisp polypeptides and therapeutical applications thereof |
| 04/17/2003 | WO2002032445A3 Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof |
| 04/17/2003 | WO2002031168A3 Minimal adenoviral vector and recombinant vaccines based thereon |
| 04/17/2003 | WO2002030974A3 Proteins and nucleic acids encoding same |
| 04/17/2003 | WO2002028901A3 Seven-transmembrane (7tm) receptors and uses thereof |
| 04/17/2003 | WO2002028900A3 Tach: new tnf-receptor family nucleic acids and polypeptides |
| 04/17/2003 | WO2002027327A3 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome |
| 04/17/2003 | WO2002026960A3 Modulation of gene expression using localization domains |
| 04/17/2003 | WO2002024891A3 B7-like molecules and uses thereof |
| 04/17/2003 | WO2002018579A3 57242, a novel human g protein-coupled receptor family member and uses therefor |
| 04/17/2003 | WO2002018576A3 Compositions and methods relating to lung specific genes |
| 04/17/2003 | WO2002018575A3 Genes expressed in the cell cycle |
| 04/17/2003 | WO2002018445A3 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 04/17/2003 | WO2002014502A3 Sclerotinia-inducible genes and promoters and their uses |
| 04/17/2003 | WO2002012508A3 Method for improved production of cyanophycin and the secondary products thereof |
| 04/17/2003 | WO2002012341A3 Her-2/neu fusion proteins |
| 04/17/2003 | WO2002004511A3 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 04/17/2003 | WO2002000721A3 Cytokine receptor zcytor17 |
| 04/17/2003 | WO2001098366A3 Enterokinase cleavage sequences and their use |
| 04/17/2003 | WO2001085210A3 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 04/17/2003 | WO2001072773A3 Genes isolated from dendritic cells, gene products and methods employing the same |
| 04/17/2003 | WO2001057275A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain |
| 04/17/2003 | WO2001057214A3 Human transporter proteins and polynucleotides encoding the same |
| 04/17/2003 | WO1999065935A3 Fas peptides and antibodies for modulating apoptosis |
| 04/17/2003 | WO1994020127A9 Hla-a2.1 binding peptides and their uses |
| 04/17/2003 | US20030074700 Expression of human milk proteins in transgenic plants |
| 04/17/2003 | US20030074699 Nucleotide sequences coding polypeptide for use in controlling flowering in plants |
| 04/17/2003 | US20030074691 Resistance to viruses and viroids in transgenic plants and animals expressing dsRNA-binding protein |
| 04/17/2003 | US20030074689 Adjusting seed phenotype in plants; obtain cells, transform with vector, recover transformed cells, propagate, mointor phenotype of aleurone cells |
| 04/17/2003 | US20030074682 Nucleotide sequences coding polypeptide for use in the cardiovascular disorders |
| 04/17/2003 | US20030074680 Generation of animal food products having amplified ribs; obtain embryos, transform with vector, implant embryo into mammal, test progeny for expression of transgene, process progeny for food |
| 04/17/2003 | US20030074678 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 04/17/2003 | US20030074142 Coincidence detection programmed media and system |
| 04/17/2003 | US20030073829 Nucleotide sequences coding polypeptides for use in the treatment of eating disorders |
| 04/17/2003 | US20030073827 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | US20030073823 Polypeptide for use in the treatment of cancer, cardiovasular disease, and immunological disorders |
| 04/17/2003 | US20030073822 Blood group antigen fusion polypeptides and method of use thereof |
| 04/17/2003 | US20030073821 Antibody for use in human therapeutics and diagnostics |
| 04/17/2003 | US20030073820 Hemoglobin conjugate for use in the synthetic blood |
| 04/17/2003 | US20030073819 PGC-1, a novel brown fat PPARgamma coactivator |
| 04/17/2003 | US20030073818 D-1 like dopamine receptor activity modifying protein |
| 04/17/2003 | US20030073817 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073816 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073815 Treatment of brain disorders; obtain adrenic acid or mimetic, administer to human, monitor adjusment in brain disorder |
| 04/17/2003 | US20030073814 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073813 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073812 Non-endogenous, constitutively activated versions of plant G protein-coupled receptor: GCR1 |
| 04/17/2003 | US20030073810 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders |
| 04/17/2003 | US20030073809 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders |
| 04/17/2003 | US20030073807 Bi-directional synthesis of oligoguanidine transport agents |
| 04/17/2003 | US20030073662 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 04/17/2003 | US20030073658 Using nucleic acids |
| 04/17/2003 | US20030073657 Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an ACT polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances |
| 04/17/2003 | US20030073656 Using a tyrosine kinase receptor inhibitor |
| 04/17/2003 | US20030073655 Alzheimer's disease |
| 04/17/2003 | US20030073652 Ex-vivo and in vivo factor XII gene therapy for hemophilia A and B |
| 04/17/2003 | US20030073651 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 04/17/2003 | US20030073637 Method for stimulating connective tissue growth or wound healing |
| 04/17/2003 | US20030073633 Mutants of bone morphogenetic proteins |
| 04/17/2003 | US20030073631 Improved pharmacological activities, pharmacokinetics and physical properties; modified with 1-acyl-glycerol derivative |
| 04/17/2003 | US20030073630 Long lasting growth hormone releasing factor derivatives |
| 04/17/2003 | US20030073629 Omi and domains thereof that disrupt IAP-caspase interaction |
| 04/17/2003 | US20030073627 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 04/17/2003 | US20030073624 Anticancer agents; isolated nucleic acids; genetic engineering |
| 04/17/2003 | US20030073623 Isolated polypeptide |
| 04/17/2003 | US20030073622 Novel proteins and nucleic acids encoding same |
| 04/17/2003 | US20030073621 Antidiabetic agents; isolated nucleic acid; genetic engineering |
| 04/17/2003 | US20030073620 Genetic engineering; antibody binding to nucleic acid; disease therapy |
| 04/17/2003 | US20030073613 Angiogenisis associated proteins, and nucleic acids encoding the same |
| 04/17/2003 | US20030073236 Adjusting cell cycle activity in sample; obtain cell, reduce expression of preferential protein in signal transduction pathway, monitor adjustment in cell cycle activity |
| 04/17/2003 | US20030073224 Ketogulonigenium endogenous plasmids |
| 04/17/2003 | US20030073220 Nucleotide sequences coding enzymatic polypeptide for use in the preparation of perfumes, adhesives and antibiotics |
| 04/17/2003 | US20030073217 Fusion protein for use in the treatment of emphysema, asthma, chronic obstructive pulmonary disease, cystic fibrosis and otitis |
| 04/17/2003 | US20030073216 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073215 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073214 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073213 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073212 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073211 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073210 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073209 Infiltrating a plant tissue with a buffer solution; subjecting plant tissue and buffer solution to a substantially vacuum environment; removing tissue from the buffer solution; centrifuging the tissue to remove interstitial fluid; |
| 04/17/2003 | US20030073208 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 04/17/2003 | US20030073199 Nucleotide sequences coding polypeptides for use in the treatment of rheumatic and rheumatoid arthritis |
| 04/17/2003 | US20030073198 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of glandular disorders |
| 04/17/2003 | US20030073196 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073195 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073194 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073193 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073192 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073191 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073190 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073189 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073188 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073187 Nucleotide sequences coding polypeptide for use in treatment and prevention of infection, induction of shock and inflammatory disease |
| 04/17/2003 | US20030073186 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073185 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073184 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073183 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073182 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073181 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |